查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球生物与医学成像试剂市场
市场调查报告书
商品编码
1813340

全球生物与医学成像试剂市场

Biological and Medical Imaging Reagents: Global Markets
出版日期: | 出版商: BCC Research | 英文 192 Pages | 订单完成后即时交付

价格

全球生物和医学影像试剂市场预计将从 2025 年的 266 亿美元成长到 2030 年底的 401 亿美元，2025 年至 2030 年期间的复合年增长率为 8.6%。

预计北美生物和医学成像试剂市场在 2025 年至 2030 年间将以 9.0% 的复合年增长率增长，从 2025 年的 113 亿美元增长到 2030 年底的 174 亿美元。

亚太地区生物和医学影像试剂市场规模预计将从 2025 年的 55 亿美元成长到 2030 年底的 86 亿美元，2025 年至 2030 年的复合年增长率为 9.8%。

调查范围

本报告概述了全球生物和医学成像试剂市场，并分析了市场趋势。报告以2024年为基准年，提供全球收益（百万美元），并预测2025年至2030年的成长情况。市场根据类型、模式、技术、应用、最终用户和地区进行细分。研究涵盖北美、欧洲、亚太、中东和非洲以及南美，并重点关注这些地区的主要国家。

本报告重点介绍了影响市场和供应商格局的主要驱动趋势和新兴技术，分析了环境、社会和治理(ESG) 发展，并讨论了与市场相关的专利和新兴技术。

报告最后进行了竞争格局分析，提供了全球主要生物和医学成像试剂公司的排名/份额。报告还包括一个专门的公司简介部分，涵盖了市场主要企业的简介。

报告内容

  • 109 个资料表和 68 个附加表
  • 全球生物及医疗图像试剂市场概况
  • 全球市场趋势分析，包括 2022 年至 2024 年的数据、2025 年的估计和预测以及预计到 2030 年的年复合成长率（CAGR）
  • 评估专业生物和医疗图像试剂的当前市场规模和收益成长前景，并按产品类型、模式、技术、应用、最终用途和地区分析市场份额
  • 这些诊断方法的分类、比较、优点、缺点，分析全球生物和医学影像诊断剂产业的当前和未来需求，以及对竞争格局、市场法规和报销实践的详细分析
  • 相关专利分析，重点在于新兴技术和新发展
  • 产业 ESG 议题与实务的考量
  • 行业主要企业的市场份额分析，以及他们的专有技术、策略联盟和其他关键市场策略的分析
  • 主要企业简介，包括 GE HealthCare、赛默飞世尔科技、西门子医疗股份公司、拜耳股份公司和 Becton, Dickinson and Co. (BD)

目录

第一章执行摘要

第二章 市场概况

  • 概述
  • 产业成长动力
  • 波特五力分析
  • 宏观经济因素分析
  • 治疗诊断学需求
  • 基于影像的侵入性和非侵入性手术
  • 慢性病的流行和投资的增加
  • 药物发现和其他研发活动
  • 多功能试剂的开发
  • 用更安全的试剂取代有毒有害检测试剂
  • 创投
  • 美国关税的影响

第三章 市场动态

  • 概述
  • 市场驱动因素
  • 增加研发投入
  • 慢性病增多
  • 治疗诊断学和个人化医疗正得到越来越广泛的应用
  • 用更安全的替代品取代有毒试剂
  • 市场限制
  • 开发和商业化成本高
  • 监管和报销挑战
  • 市场机会
  • AI在生医研发及医疗图像试剂领域的应用
  • 多功能成像剂的出现
  • 市场挑战
  • 安全问题
  • 保质期短和稳定性问题

第四章：监理现状

  • 各国/地区的监管核准流程
  • 美国
  • 欧洲联盟
  • 亚太地区

第五章 新兴技术与发展

  • 关键要点
  • 奈米粒子
  • 用于单细胞和蛋白质组学应用的下一代成像试剂
  • 生物和医学成像试剂中的人工智慧和机器学习
  • 利用近红外线技术进行创新的横向流动化验
  • 萤光染料和混合靶向平台
  • 新型放射性示踪剂可提高肿瘤学诊断的准确性
  • 专利分析
  • 主要发现

第六章 市场区隔分析

  • 细分市场
  • 按产品类型进行市场分析
  • 关键要点
  • 显影剂
  • 放射性试剂
  • 光学试剂
  • 按模式进行市场分析
  • 关键要点
  • 光学成像试剂
  • X射线/CT试剂
  • 核子造影试剂
  • MRI成像试剂
  • 多模态成像试剂
  • 超音波成像试剂
  • 依技术进行市场分析
  • 关键要点
  • 量子点
  • 放射性药物
  • 萤光蛋白
  • 萤光染料和探针
  • 奈米粒子
  • 按应用进行市场分析
  • 关键要点
  • 体内成像试剂
  • 体外成像试剂
  • 按最终用途进行市场分析
  • 关键要点
  • 诊断
  • 研究与开发
  • 区域分布
  • 区域市场分析
  • 关键要点
  • 北美洲
  • 欧洲
  • 亚太地区
  • 南美洲
  • 中东和非洲

第七章 竞争讯息

  • 关键要点
  • 主要企业全球市场份额
  • 关键发展和策略
  • 伙伴关係与合作
  • 获得
  • 业务扩展
  • 产品发布和FDA核准

第八章生物和医学成像试剂市场的永续性：ESG视角

第九章 附录

  • 调查方法
  • 简称
  • 来源
  • 公司简介
  • AGILENT TECHNOLOGIES INC.
  • ALTONA DIAGNOSTICS GMBH
  • ANALYTIK JENA GMBH+CO. KG.
  • BAYER AG
  • BD
  • BIO-RAD LABORATORIES INC.
  • DANAHER CORP.
  • F. HOFFMANN-LA ROCHE LTD.
  • GE HEALTHCARE
  • MERCK KGAA
  • PROMEGA CORP.
  • QIAGEN
  • REVVITY
  • SIEMENS HEALTHINEERS AG
  • THERMO FISHER SCIENTIFIC INC.
  • 一些Start-Ups创公司/市场颠覆者
Product Code: HLC040F

The global market for biological and medical imaging reagents is estimated to grow from $26.6 billion in 2025 and forecast to reach $40.1 billion by the end of 2030, at a compound annual growth rate (CAGR) of 8.6% from 2025 to 2030.

The North American market for biological and medical imaging reagents is estimated to grow from $11.3 billion in 2025 and forecast to reach $17.4 billion by the end of 2030, at a CAGR of 9.0% from 2025 to 2030.

The Asia-Pacific market for biological and medical imaging reagents is estimated to grow from $5.5 billion in 2025 and forecast to reach $8.6 billion by the end of 2030, at a CAGR of 9.8% from 2025 to 2030.

Report Scope

The report provides an overview of the global biological and medical imaging reagent market and analyzes market trends. It includes global revenue ($ millions) using 2024 as the base year, and the forecast from 2025 through 2030. The market is segmented based on type, modality, technology, application end user, and region. The regions covered in this study include North America, Europe, Asia-Pacific, the Middle East and Africa (MEA), and South America, focusing on major countries in these regions.

The report focuses on the significant driving trends and emerging technologies that influence the market and vendor landscape. It analyzes environmental, social and corporate governance (ESG) developments and discusses patents and emerging technologies related to the market.

The report concludes with an analysis of the competitive landscape, providing the ranking/share of key global biological and medical imaging reagent companies. It also has a dedicated section of company profiles covering the profiles of leading companies in the market.

Report Includes

  • 109 data tables and 68 additional tables
  • An overview of the global market for biological and medical imaging reagents
  • Analyses of the global market trends, with data from 2022-2024, estimates for 2025, and projections of compound annual growth rates (CAGRs) through 2030
  • Evaluation of the current market size and revenue growth prospects specific to the biologic and medical imaging reagents, accompanied by a market share analysis by product type, modality, technology, application, end use, and region
  • A look at classifications, comparisons, advantages, and disadvantages of these types of diagnostic methods, and analysis of current and future demand in the global biologic and medical imaging reagents industry, along with a detailed analysis of the competitive environment, market regulations and reimbursement practices
  • A relevant patent analysis with emphasis on emerging technologies and new developments
  • A discussion on ESG challenges and practices of the industry
  • Market share analysis of the key companies of the industry and coverage of their proprietary technologies, strategic alliances, and other key market strategies
  • Company profiles of the leading market players, including GE HealthCare, Thermo Fisher Scientific Inc., Siemens Healthineers AG, Bayer AG and Becton, Dickinson and Co. (BD)

Table of Contents

Chapter 1 Executive Summary

  • Market Outlook
  • Scope of the Report
  • Market Summary
  • Market Dynamics and Growth Factors
  • Emerging Technologies
  • Segmental Analysis
  • Regional Analysis
  • Conclusion

Chapter 2 Market Overview

  • Overview
  • Forces Driving Industry Growth
  • Porter's Five Forces Analysis
  • Potential for New Entrants (Moderate to High)
  • Bargaining Power of Suppliers (Moderate)
  • Bargaining Power of Buyers (Moderate)
  • Threat of Substitutes (Low to Moderate)
  • Industry Competition (High)
  • Macroeconomic Factors Analysis
  • Demand for Theranostics
  • Image-based Invasive and Noninvasive Procedures
  • Prevalence of Chronic Diseases and Rising Investments
  • Drug Discovery and Other R&D Activities
  • Development of Multifunctional Reagent Capabilities
  • Replacement of Toxic, Hazardous Detection Reagents with Safer Reagents
  • VC Investment
  • Impact of U.S. Tariff

Chapter 3 Market Dynamics

  • Overview
  • Market Drivers
  • Increasing Investments in R&D
  • Growing Prevalence of Chronic Diseases
  • Rising Adoption of Theranostics and Personalized Medicine
  • Replacement of Toxic Reagents with Safer Alternatives
  • Market Restraints
  • High Development and Commercialization Costs
  • Regulatory and Reimbursement Challenges
  • Market Opportunities
  • Integration of AI in Biologics R&D and Medical Imaging Reagents
  • Emergence of Multifunctional Imaging Reagents
  • Market Challenges
  • Safety Concerns
  • Short Shelf Life and Stability Issues

Chapter 4 Regulatory Landscape

  • Regulatory Approval Process, by Select Country/Region
  • U.S.
  • European Union
  • Asia-Pacific

Chapter 5 Emerging Technologies and Developments

  • Key Takeaways
  • Nanoparticles
  • Next-Generation Imaging Reagents for Single-Cell and Proteomic Applications
  • AI and ML in Biological and Medical Imaging Reagents
  • Innovative Lateral Flow Assays Enhanced by NIR Technology
  • Fluorochromes and Hybrid Targeting Platforms
  • Emerging Radiotracers Enhancing Diagnostic Accuracy in Oncology
  • Patent Analysis
  • Key Findings

Chapter 6 Market Segment Analysis

  • Segmentation Breakdown
  • Market Analysis by Product Type
  • Key Takeaways
  • Contrast Reagents
  • Radioactive Reagents
  • Optical Reagents
  • Market Analysis by Modality
  • Key Takeaways
  • Optical Imaging Reagents
  • X-ray/CT Reagents
  • Nuclear Imaging Reagents
  • MRI Imaging Reagents
  • Multimodal Imaging Reagents
  • Ultrasound Imaging Reagents
  • Market Analysis by Technology
  • Key Takeaways
  • Quantum Dots
  • Radiopharmaceuticals
  • Fluorescent Proteins
  • Fluorescent Dyes and Probes
  • Nanoparticles
  • Market Analysis by Application
  • Key Takeaways
  • In Vivo Imaging Reagents
  • In Vitro Imaging Reagents
  • Market Analysis by End Use
  • Key Takeaways
  • Diagnostics
  • R&D
  • Geographic Breakdown
  • Market Analysis by Region
  • Key Takeaways
  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East and Africa

Chapter 7 Competitive Intelligence

  • Key Takeaways
  • Global Market Shares of Leading Companies
  • Key Developments and Strategies
  • Partnerships and Collaborations
  • Acquisitions
  • Business Expansions
  • Product Launches and FDA Approvals

Chapter 8 Sustainability in Biological and Medical Imaging Reagents Market: ESG Perspective

  • Introduction to ESG
  • Steps Toward Sustainable Use of Biologics and Medical Imaging Reagents
  • Major Manufacturers: ESG Efforts
  • ESG Risk Ratings
  • Concluding Remarks from BCC

Chapter 9 Appendix

  • Methodology
  • Abbreviations
  • Sources
  • Company Profiles
  • AGILENT TECHNOLOGIES INC.
  • ALTONA DIAGNOSTICS GMBH
  • ANALYTIK JENA GMBH+CO. KG.
  • BAYER AG
  • BD
  • BIO-RAD LABORATORIES INC.
  • DANAHER CORP.
  • F. HOFFMANN-LA ROCHE LTD.
  • GE HEALTHCARE
  • MERCK KGAA
  • PROMEGA CORP.
  • QIAGEN
  • REVVITY
  • SIEMENS HEALTHINEERS AG
  • THERMO FISHER SCIENTIFIC INC.
  • Few Emerging Start-ups/Market Disruptors

List of Tables

  • Summary Table : Global Market for Biological and Medical Imaging Reagents, by Region, Through 2030
  • Table 1 : Biological Imaging Reagents: Forces Driving Growth
  • Table 2 : Porter's Five Forces: Rating Scale
  • Table 3 : Current and Future Invasive and Noninvasive Imaging Technologies
  • Table 4 : Life Cycle Stage of Biological Imaging Reagents
  • Table 5 : Pharmaceutical R&D Expenditure in Selected Countries, 2023
  • Table 6 : Incidence and Mortality Rates of Cancer Across Regions, 2022
  • Table 7 : Nanoparticles in Imaging Applications
  • Table 8 : Select Published Patents on Biological and Medical Imaging Reagents, May 2025
  • Table 9 : Global Market for Biological and Medical Imaging Reagents, by Product Type, Through 2030
  • Table 10 : Global Market for Contrast Reagents, by Region, Through 2030
  • Table 11 : Global Market for Radioactive Reagents, by Region, Through 2030
  • Table 12 : Global Market for Optical Reagents, by Region, Through 2030
  • Table 13 : Global Market for Biological and Medical Imaging Reagents, by Modality, Through 2030
  • Table 14 : Global Market for Optical Imaging Reagents, by Region, Through 2030
  • Table 15 : Global Market for X-ray/CT Imaging Reagents, by Region, Through 2030
  • Table 16 : Global Market for Nuclear Imaging Reagents, by Region, Through 2030
  • Table 17 : Key Brands of Gd-Based Contrast Reagents Worldwide
  • Table 18 : Global Market for MRI Imaging Reagents, by Region, Through 2030
  • Table 19 : Global Market for Multimodal Imaging Reagents, by Region, Through 2030
  • Table 20 : Global Market for Ultrasound Imaging Reagents, by Region, Through 2030
  • Table 21 : Global Market for Biological and Medical Imaging Reagents, by Technology, Through 2030
  • Table 22 : Biological Imaging Applications of QDs
  • Table 23 : Global Market for QDs Technology-based Imaging Reagents, by Region, Through 2030
  • Table 24 : Global Market for Radiopharmaceuticals Technology-based Imaging Reagents, by Region, Through 2030
  • Table 25 : Types of FPs
  • Table 26 : Global Market for FPs Technology-based Imaging Reagents, by Region, Through 2030
  • Table 27 : Fluorescent Dyes and Probes
  • Table 28 : Global Market for Fluorescent Dyes and Probes Technology-based Imaging Reagents, by Region, Through 2030
  • Table 29 : Global Market for Nanoparticle Technology-based Imaging Reagents, by Region, Through 2030
  • Table 30 : Global Market for Biological and Medical Imaging Reagents, by Application, Through 2030
  • Table 31 : Biological Imaging Reagents Applications
  • Table 32 : Global Market for In Vivo Imaging Reagents, by Region, Through 2030
  • Table 33 : Significance of Medical Imaging Reagents to the Life Sciences and Medical Industries
  • Table 34 : Global Market for In Vitro Imaging Reagents, by Region, Through 2030
  • Table 35 : Global Market for Biological and Medical Imaging Reagents, by End Use, Through 2030
  • Table 36 : Global Market for Diagnostics Imaging Reagents, by Region, Through 2030
  • Table 37 : Global Market for R&D Imaging Reagents, by Region, Through 2030
  • Table 38 : Global Market for Biological and Medical Imaging Reagents, by Region, Through 2030
  • Table 39 : North American Market for Biological and Medical Imaging Reagents, by Product Type, Through 2030
  • Table 40 : North American Market for Biological and Medical Imaging Reagents, by Modality, Through 2030
  • Table 41 : North American Market for Biological and Medical Imaging Reagents, by Technology, Through 2030
  • Table 42 : North American Market for Biological and Medical Imaging Reagents, by Application, Through 2030
  • Table 43 : North American Market for Biological and Medical Imaging Reagents, by End Use, Through 2030
  • Table 44 : North American Market for Biological and Medical Imaging Reagents, by Country, Through 2030
  • Table 45 : U.S. Market for Biological and Medical Imaging Reagents, by Product Type, Through 2030
  • Table 46 : U.S. Market for Biological and Medical Imaging Reagents, by Application, Through 2030
  • Table 47 : U.S. Market for Biological and Medical Imaging Reagents, by End Use, Through 2030
  • Table 48 : Canadian Market for Biological and Medical Imaging Reagents, by Product Type, Through 2030
  • Table 49 : Canadian Market for Biological and Medical Imaging Reagents, by Application, Through 2030
  • Table 50 : Canadian Market for Biological and Medical Imaging Reagents, by End Use, Through 2030
  • Table 51 : Mexican Market for Biological and Medical Imaging Reagents, by Product Type, Through 2030
  • Table 52 : Mexican Market for Biological and Medical Imaging Reagents, by Application, Through 2030
  • Table 53 : Mexican Market for Biological and Medical Imaging Reagents, by End Use, Through 2030
  • Table 54 : European Market for Biological and Medical Imaging Reagents, by Product Type, Through 2030
  • Table 55 : European Market for Biological and Medical Imaging Reagents, by Modality, Through 2030
  • Table 56 : European Market for Biological and Medical Imaging Reagents, by Technology, Through 2030
  • Table 57 : European Market for Biological and Medical Imaging Reagents, by Application, Through 2030
  • Table 58 : European Market for Biological and Medical Imaging Reagents, by End Use, Through 2030
  • Table 59 : European Market for Biological and Medical Imaging Reagents, by Country, Through 2030
  • Table 60 : U.K. Market for Biological and Medical Imaging Reagents, by Product Type, Through 2030
  • Table 61 : U.K. Market for Biological and Medical Imaging Reagents, by Application, Through 2030
  • Table 62 : U.K. Market for Biological and Medical Imaging Reagents, by End Use, Through 2030
  • Table 63 : French Market for Biological and Medical Imaging Reagents, by Product Type, Through 2030
  • Table 64 : French Market for Biological and Medical Imaging Reagents, by Application, Through 2030
  • Table 65 : French Market for Biological and Medical Imaging Reagents, by End Use, Through 2030
  • Table 66 : Italian Market for Biological and Medical Imaging Reagents, by Product Type, Through 2030
  • Table 67 : Italian Market for Biological and Medical Imaging Reagents, by Application, Through 2030
  • Table 68 : Italian Market for Biological and Medical Imaging Reagents, by End Use, Through 2030
  • Table 69 : German Market for Biological and Medical Imaging Reagents, by Product Type, Through 2030
  • Table 70 : German Market for Biological and Medical Imaging Reagents, by Application, Through 2030
  • Table 71 : German Market for Biological and Medical Imaging Reagents, by End Use, Through 2030
  • Table 72 : Spanish Market for Biological and Medical Imaging Reagents, by Product Type, Through 2030
  • Table 73 : Spanish Market for Biological and Medical Imaging Reagents, by Application, Through 2030
  • Table 74 : Spanish Market for Biological and Medical Imaging Reagents, by End Use, Through 2030
  • Table 75 : Rest of Europe Market for Biological and Medical Imaging Reagents, by Product Type, Through 2030
  • Table 76 : Rest of Europe Market for Biological and Medical Imaging Reagents, by Application, Through 2030
  • Table 77 : Rest of Europe Market for Biological and Medical Imaging Reagents, by End Use, Through 2030
  • Table 78 : Asia-Pacific Market for Biological and Medical Imaging Reagents, by Product Type, Through 2030
  • Table 79 : Asia-Pacific Market for Biological and Medical Imaging Reagents, by Modality, Through 2030
  • Table 80 : Asia-Pacific Market for Biological and Medical Imaging Reagents, by Technology, Through 2030
  • Table 81 : Asia-Pacific Market for Biological and Medical Imaging Reagents, by Application, Through 2030
  • Table 82 : Asia-Pacific Market for Biological and Medical Imaging Reagents, by End Use, Through 2030
  • Table 83 : Asia-Pacific Market for Biological and Medical Imaging Reagents, by Country, Through 2030
  • Table 84 : Chinese Market for Biological and Medical Imaging Reagents, by Product Type, Through 2030
  • Table 85 : Chinese Market for Biological and Medical Imaging Reagents, by Application, Through 2030
  • Table 86 : Chinese Market for Biological and Medical Imaging Reagents, by End Use, Through 2030
  • Table 87 : Indian Market for Biological and Medical Imaging Reagents, by Product Type, Through 2030
  • Table 88 : Indian Market for Biological and Medical Imaging Reagents, by Application, Through 2030
  • Table 89 : Indian Market for Biological and Medical Imaging Reagents, by End Use, Through 2030
  • Table 90 : Japanese Market for Biological and Medical Imaging Reagents, by Product Type, Through 2030
  • Table 91 : Japanese Market for Biological and Medical Imaging Reagents, by Application, Through 2030
  • Table 92 : Japanese Market for Biological and Medical Imaging Reagents, by End Use, Through 2030
  • Table 93 : Australian Market for Biological and Medical Imaging Reagents, by Product Type, Through 2030
  • Table 94 : Australian Market for Biological and Medical Imaging Reagents, by Application, Through 2030
  • Table 95 : Australian Market for Biological and Medical Imaging Reagents, by End Use, Through 2030
  • Table 96 : Rest of Asia-Pacific Market for Biological and Medical Imaging Reagents, by Product Type, Through 2030
  • Table 97 : Rest of Asia-Pacific Market for Biological and Medical Imaging Reagents, by Application, Through 2030
  • Table 98 : Rest of Asia-Pacific Market for Biological and Medical Imaging Reagents, by End Use, Through 2030
  • Table 99 : South American Market for Biological and Medical Imaging Reagents, by Product Type, Through 2030
  • Table 100 : South American Market for Biological and Medical Imaging Reagents, by Modality, Through 2030
  • Table 101 : South American Market for Biological and Medical Imaging Reagents, by Technology, Through 2030
  • Table 102 : South American Market for Biological and Medical Imaging Reagents, by Application, Through 2030
  • Table 103 : South American Market for Biological and Medical Imaging Reagents, by End Use, Through 2030
  • Table 104 : MEA Market for Biological and Medical Imaging Reagents, by Product Type, Through 2030
  • Table 105 : MEA Market for Biological and Medical Imaging Reagents, by Modality, Through 2030
  • Table 106 : MEA Market for Biological and Medical Imaging Reagents, by Technology, Through 2030
  • Table 107 : MEA Market for Biological and Medical Imaging Reagents, by Application, Through 2030
  • Table 108 : MEA Market for Biological and Medical Imaging Reagents, by End Use, Through 2030
  • Table 109 : Leading Manufacturers in the Biological and Medical Imaging Reagent Market, 2024
  • Table 110 : Collaborations and Partnerships: Biological and Medical Imaging Reagents Market, 2022-2025
  • Table 111 : Acquisition: Biological and Medical Imaging Reagents Market, 2022-2025
  • Table 112 : Business Expansion Activities: Biological and Medical Imaging Reagents Market, 2023-2025
  • Table 113 : Product Launches and FDA Approval Activities: Biological and Medical Imaging Reagents Market, 2022-2025
  • Table 114 : Examples of Current Imaging Agents and Their Potential Concerns
  • Table 115 : ESG Highlights, by Major Players, 2024
  • Table 116 : ESG Risk Rankings for Biological and Medical Imaging Reagents Market, by Manufacturing Companies, 2024
  • Table 117 : Abbreviations Used in This Report
  • Table 118 : Report Information Sources
  • Table 119 : Agilent Technologies Inc.: Company Snapshot
  • Table 120 : Agilent Technologies Inc.: Financial Performance, FY 2023 and 2024
  • Table 121 : Agilent Technologies Inc.: Product Portfolio
  • Table 122 : Agilent Technologies Inc.: News/Key Developments, 2023 and 2024
  • Table 123 : Altona Diagnostic GmbH.: Company Snapshot
  • Table 124 : Altona Diagnostic GmbH.: Product Portfolio
  • Table 125 : Altona Diagnostic GmbH: News/Key Developments, 2022-2025
  • Table 126 : Analytik Jena GmbH+Co. KG: Company Snapshot
  • Table 127 : Analytik Jena GmbH+Co. KG: Product Portfolio
  • Table 128 : Analytik Jena GmbH+Co. KG: News/Key Developments, 2023 and 2024
  • Table 129 : Bayer AG: Company Snapshot
  • Table 130 : Bayer AG: Financial Performance, FY 2023 and 2024
  • Table 131 : Bayer AG: Product Portfolio
  • Table 132 : Bayer AG: News/Key Developments, 2024 and 2025
  • Table 133 : BD: Company Snapshot
  • Table 134 : BD: Financial Performance, FY 2023 and 2024
  • Table 135 : BD: Product Portfolio
  • Table 136 : BD: News/Key Developments, 2022-2024
  • Table 137 : Bio-Rad Laboratories Inc.: Company Snapshot
  • Table 138 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2023 and 2024
  • Table 139 : Bio-Rad Laboratories Inc.: Product Portfolio
  • Table 140 : Bio-Rad Laboratories Inc.: News/Key Developments, 2022-2025
  • Table 141 : Danaher Corp.: Company Snapshot
  • Table 142 : Danaher Corp.: Financial Performance, FY 2023 and 2024
  • Table 143 : Danaher Corp.: Product Portfolio
  • Table 144 : Danaher Corp.: News/Key Developments, 2021-2023
  • Table 145 : F. Hoffmann-La Roche Ltd.: Company Snapshot
  • Table 146 : F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2023 and 2024
  • Table 147 : F. Hoffmann-La Roche Ltd.: Product Portfolio
  • Table 148 : F. Hoffmann-La Roche Ltd.: News/Key Developments, 2023 and 2024
  • Table 149 : GE HealthCare: Company Snapshot
  • Table 150 : GE HealthCare: Financial Performance, FY 2023 and 2024
  • Table 151 : GE HealthCare: Product Portfolio
  • Table 152 : GE HealthCare: News/Key Developments, 2024 and 2025
  • Table 153 : Merck KGaA: Company Snapshot
  • Table 154 : Merck KGaA: Financial Performance, FY 2023 and 2024
  • Table 155 : Merck KGaA.: Product Portfolio
  • Table 156 : Merck KGaA: News/Key Developments, 2022-2025
  • Table 157 : Promega Corp.: Company Snapshot
  • Table 158 : Promega Corp.: Product Portfolio
  • Table 159 : Promega Corp.: News/Key Developments, 2023-2025
  • Table 160 : Qiagen: Company Snapshot
  • Table 161 : Qiagen: Financial Performance, FY 2023 and 2024
  • Table 162 : Qiagen: Product Portfolio
  • Table 163 : Qiagen: News/Key Developments, 2023-2025
  • Table 164 : Revvity: Company Snapshot
  • Table 165 : Revvity: Financial Performance, FY 2023 and 2024
  • Table 166 : Revvity: Product Portfolio
  • Table 167 : Revvity: News/Key Developments, 2023-2025
  • Table 168 : Siemens Healthineers AG: Company Snapshot
  • Table 169 : Siemens Healthineers AG: Financial Performance, FY 2023 and 2024
  • Table 170 : Siemens Healthineers AG: Product Portfolio
  • Table 171 : Siemens Healthineers AG: Key Developments, 2022-2024
  • Table 172 : Thermo Fisher Scientific Inc.: Company Snapshot
  • Table 173 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2023 and 2024
  • Table 174 : Thermo Fisher Scientific Inc.: Product Portfolio
  • Table 175 : Thermo Fisher Scientific Inc.: News/Key Developments, 2022-2024
  • Table 176 : List of a Few Emerging Startups/Market Disruptors

List of Figures

  • Summary Figure : Global Market Shares of Biological and Medical Imaging Reagents, by Region, 2024
  • Figure 1 : Factors Impacting the Growth of the Biological Imaging Reagent Market, 2024 and 2030
  • Figure 2 : Global Pharmaceutical R&D Spending, by Select Country/Region, 2010-2022
  • Figure 3 : Market Dynamics of Biological and Medical Imaging Reagents
  • Figure 4 : Personalized Medicines' Contribution to Total FDA Approvals, 2015-2023
  • Figure 5 : Number of Patents Documented on Biological and Medical Imaging Reagents, by Leading Applicants, January 2024-May 2024
  • Figure 6 : Patent Shares on Biological and Medical Imaging Reagents, by Jurisdiction, January 2024-May 2025
  • Figure 7 : Patent Shares on Biological and Medical Imaging Reagents, by Type, January 2024-May 2025
  • Figure 8 : Global Market Shares of Biological and Medical Imaging Reagents, by Product Type, 2024
  • Figure 9 : Global Market Shares of Biological and Medical Imaging Reagents, by Modality, 2024
  • Figure 10 : Global Market Shares of Biological and Medical Imaging Reagents, by Technology, 2024
  • Figure 11 : Global Market Shares of Biological and Medical Imaging Reagents, by Technology, 2024
  • Figure 12 : Global Market Shares of Biological and Medical Imaging Reagents, by End Use, 2024
  • Figure 13 : Global Market Shares of Biological and Medical Imaging Reagents, by Region, 2024
  • Figure 14 : Company Share Analysis of Global Biological and Medical Imaging Reagent Market, 2024
  • Figure 15 : 3C Guidelines for the Handling and Design and of Medical Imaging Agents To Reduce the Pollution and Facilitate Ecologically Friendly Solutions
  • Figure 16 : Agilent Technologies Inc.: Revenue Share, by Business Unit, FY 2024
  • Figure 17 : Agilent Technologies Inc.: Revenue Share, by Country/Region, FY 2024
  • Figure 18 : Bayer AG: Revenue Share, by Business Unit, FY 2024
  • Figure 19 : Bayer AG: Revenue Share, by Country/Region, FY 2024
  • Figure 20 : BD: Revenue Share, by Business Unit, FY 2024
  • Figure 21 : BD: Revenue Share, by Country/Region, FY 2024
  • Figure 22 : Bio-Rad Laboratories Inc.: Revenue Share, by Business Unit, FY 2024
  • Figure 23 : Bio-Rad Laboratories Inc.: Revenue Share, by Country/Region, FY 2024
  • Figure 24 : Danaher Corp.: Revenue Share, by Business Unit, FY 2024
  • Figure 25 : Danaher Corp.: Revenue Share, by Country/Region, FY 2024
  • Figure 26 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, FY 2024
  • Figure 27 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, FY 2024
  • Figure 28 : GE HealthCare: Revenue Share, by Business Unit, FY 2024
  • Figure 29 : GE HealthCare: Revenue Share, by Country/Region, FY 2024
  • Figure 30 : Merck KGaA: Revenue Share, by Business Unit, FY 2024
  • Figure 31 : Merck KGaA: Revenue Share, by Country/Region, FY 2024
  • Figure 32 : Qiagen: Revenue Share, by Business Unit, FY 2024
  • Figure 33 : Qiagen: Revenue Share, by Country/Region, FY 2024
  • Figure 34 : Revvity: Revenue Share, by Business Unit, FY 2024
  • Figure 35 : Revvity: Revenue Share, by Country/Region, FY 2024
  • Figure 36 : Siemens Healthineers AG: Revenue Share, by Business Unit, FY 2024
  • Figure 37 : Siemens Healthineers AG: Revenue Share, by Country/Region, FY 2024
  • Figure 38 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2024
  • Figure 39 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2024